Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Nice
Clinical trial register · France

Clinical Trials in Nice, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9697 matching records held by the registry are in this view. Synced 26 Oct 2026, 03:20 UTC
9697
Studies in scope
all four open statuses
6025
Recruiting now
open to new participants
1033
Lead sponsors
across recruiting studies
Top sites
Paris 2821 Lyon 1392 Bordeaux 1389 Marseille 1285 Lille 1282
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Centre Hospitalier Universitaire de Nice194 AbbVie32 Merck Sharp & Dohme LLC21 Novartis Pharmaceuticals20 Centre Antoine Lacassagne19
Site location
Paris2821 Lyon1392 Bordeaux1389 Marseille1285 Lille1282
All 804 locations
Target enrolment
to

Trials with a site in Nice

768 of 9697 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours
NCT05752552Adult Solid Tumor, Advanced Solid Tumor, Refractory Tumor, Non-small Cell Lung Cancer
DeuterOncology
Phase 1
55
Bordeaux, Lille, Lyon, Marseille, Nice, Rennes, Villejuif
2022-12-20
Recruiting
PPI Supplementation to Fight ECtopIc Calcification in PXE
NCT04868578Pseudoxanthoma Elasticum
Centre Hospitalier Universitaire de Nice
Not applicable
99
Angers, Nice
2022-12-13
Recruiting
Pharming Technologies B.V.
Phase 2
180
Angers, Bordeaux, Lille, Nantes, Nice, Paris, Strasbourg
2022-12-13
Active, closed
Novartis Pharmaceuticals
Observational
1,019
Nice, Marseille, Dijon, Saint-Denis, Valenciennes, Saint-Cloud, Grenoble, Reims
2022-12-13
Active, closed
Novartis Pharmaceuticals
Phase 3
696
Angers, Antony, Bordeaux, Brest, Montpellier, Nice, Paris, Pierre-Bénite
2022-12-09
Recruiting
Assistance Publique Hopitaux De Marseille
Observational
80
Bordeaux, Marseille, Montpellier, Nantes, Nice, Nîmes, Paris, Toulouse
2022-12-07
Recruiting
CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome
NCT05623150Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Alcohol-related Liver Disease, Cirrhosis, Liver
Institut National de la Santé Et de la Recherche Médicale, France
Observational
710
Nice
2022-12-06
Recruiting
University Hospital, Montpellier
Phase 3
220
Montpellier, Bordeaux, Brest, Cahors, La Roche-sur-Yon, Le Mans, Nantes, Nice
2022-11-28
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
30
Nice
2022-11-23
Active, closed
Groupe Francophone des Myelodysplasies
Phase 1/2
55
Angers, Grenoble, Limoges, Montpellier, Nantes, Nice, Paris, Pessac
2022-11-23
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
297
Bron, Créteil, Lille, Marseille, Montpellier, Nantes, Nice, Paris
2022-11-23
Active, closed
Novartis Pharmaceuticals
Phase 3
568
Bordeaux, Caen, Clermont-Ferrand, Lille, Lyon, Marseille, Nantes, Nice
2022-11-21
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
260
Garches, Lille, Marseille, Nice, Paris, Strasbourg
2022-11-21
Active, closed
Dazucorilant in Patients With Amyotrophic Lateral Sclerosis
NCT05407324Amyotrophic Lateral Sclerosis
Corcept Therapeutics
Phase 2
279
Bron, Lille, Limoges, Marseille, Montpellier, Nice, Paris, Tours
2022-11-15
Recruiting
Pfizer
Phase 3
1,060
Nice, Toulouse, Poitiers, Nantes, Paris, Tours, Villejuif
2022-11-10
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
822
Bordeaux, Bron, Créteil, Lille, Montpellier, Nice, Paris, Pierre-Bénite
2022-11-08
Active, closed
Almirall, S.A.
Phase 4
447
Lille, Marseille, Nice, Paris, Rouen, Saint-Priest-en-Jarez
2022-10-24
Active, closed
Assessment of Circulating Fubctional Mitochondrias in Vitiligo Patients
NCT05525741Skin and Connective Tissue Diseases
Centre Hospitalier Universitaire de Nice
Not applicable
59
Nice
2022-10-19
Active, closed
Janssen Research & Development, LLC
Phase 3
864
Créteil, Dijon, Lyon, Montpellier, Nantes, Nice, Paris, Pessac
2022-10-13
Active, closed
Eli Lilly and Company
Phase 3
15,374
Corbeil-Essonnes, La Tronche, Le Coudray, Le Creusot, Limoges, Nice, Paris, Pierre-Bénite
2022-10-11
Active, closed
NEAT ID Foundation
Observational
500
Montpellier, Nantes, Nice, Paris
2022-10-10
Recruiting
University Hospital, Bordeaux
Not applicable
336
Aix-en-Provence, Angers, Bordeaux, Créteil, Lille, Limoges, Marseille, Nice
2022-09-29
Active, closed
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
NCT05347095Fistulizing Crohns Disease, Perianal Crohns Disease
DrugGuselkumab
Janssen-Cilag Ltd.
Phase 3
288
Neuilly-sur-Seine, Nice, Paris, Pierre-Bénite, Rennes, Vandœuvre-lès-Nancy
2022-09-27
Recruiting
EMDR Therapy in Young Children, a Double-blinded Randomized Controlled Trial
NCT05419934Trauma, Psychological, Stress, Psychological, Anxiety Disorders
Fondation Lenval
Not applicable
60
Nice
2022-09-27
Recruiting
Janssen Research & Development, LLC
Phase 2/3
201
Bordeaux, Bron, Le Kremlin-Bicêtre, Marseille, Nice, Nîmes, Paris, Strasbourg
2022-09-23
Active, closed
Janssen Research & Development, LLC
Phase 3
418
Besançon, Le Kremlin-Bicêtre, Montpellier, Neuilly-sur-Seine, Nice, Nîmes, Pessac, Pierre-Bénite
2022-09-13
Active, closed
Biogen
Phase 2/3
450
Nice, Marseille, Caen, Besançon, Toulouse, Antony, Montpellier, Lille
2022-09-13
Recruiting
Thromboxane A2 and Osteoarthritis
NCT05593640Osteoarthritis
Centre Hospitalier Universitaire de Nice
Observational
20
Nice
2022-09-01
Active, closed
Madrigal Pharmaceuticals, Inc.
Phase 3
845
Lyon, Vandœuvre-lès-Nancy, Lille, Clichy, Créteil, Nice, Paris, Strasbourg
2022-08-26
Active, closed
Sanofi
Phase 2/3
1,856
Antony, Bordeaux, Clermont-Ferrand, Créteil, Lille, Nice, Reims, Rouen
2022-08-22
Active, closed
Gilead Sciences
Phase 2/3
689
Nice, Paris
2022-08-16
Active, closed
AbbVie
Observational
785
Nice, Marseille, Besançon, Nîmes, Colmar, Toulouse, Montpellier, La Tronche
2022-08-15
Recruiting
Systolic Function and Weaning-induced Pulmonary Edema (SystoWean Study)
NCT05226247Mechanical Ventilation Complication, Pulmonary Edema
Centre Hospitalier Universitaire de Nice
Not applicable
250
Dijon, Nice, Paris
2022-08-08
Active, closed
Bausch Health Americas, Inc.
Phase 3
466
Angers, Belfort, Besançon, Clermont-Ferrand, Limoges, Lyon, Nice, Paris
2022-08-03
Active, closed
Janssen Research & Development, LLC
Phase 2
703
Amiens, Besançon, Créteil, Grenoble, Marseille, Nantes, Neuilly-sur-Seine, Nice
2022-07-22
Recruiting
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
NCT05254743Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell, Small Lymphocytic Lymphoma
DrugsPirtobrutinib·Ibrutinib
Loxo Oncology, Inc.
Phase 3
737
La Roche-sur-Yon, Le Mans, Limoges, Nantes, Nice, Paris, Pierre-Bénite, Rennes
2022-07-22
Active, closed
Genzyme, a Sanofi Company
Phase 4
17
Bordeaux, Brest, Clermont-Ferrand, Lille, Lyon, Marseille, Nantes, Nice
2022-07-11
Active, closed
Janssen Research & Development, LLC
Phase 2
36
Nice, Paris, Strasbourg
2022-07-05
Active, closed
Keri Medical SA
Observational
97
Aix-en-Provence, Beaumont, Bourgoin, Nice, Perpignan, Périgueux
2022-07-05
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
100
Nice
2022-06-30
Active, closed
Corcept Therapeutics
Phase 3
381
Lille, Montpellier, Nancy, Nice, Paris, Plérin
2022-06-29
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
75
Nice
2022-06-10
Recruiting
Telios Pharma, Inc.
Phase 1/2
70
Angers, Marseille, Nice, Paris, Pierre-Bénite
2022-06-09
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
20
Nice
2022-05-25
Active, closed
IO Biotech
Phase 3
407
Besançon, Bordeaux, Boulogne-Billancourt, Dijon, La Tronche, Lille, Marseille, Nice
2022-05-17
Recruiting
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
30
Besançon, Bordeaux, Lille, Limoges, Lyon, Montpellier, Nice, Paris
2022-05-05
Active, closed
Hoffmann-La Roche
Phase 3
1,300
Caen, Nancy, Bordeaux, Bron, Clermont-Ferrand, Lille, Nice, Poissy
2022-05-03
Active, closed
Pierre Fabre Medicament
Phase 3
815
Nice, Marseille, Dijon, Bordeaux, Toulouse, Boulogne-Billancourt, Rennes, Chambray-lès-Tours
2022-05-02
Recruiting
PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy
NCT05055648Esophageal Cancer, Radiotherapy, Side Effect, Proton Therapy
University of Aarhus
Phase 3
396
Lyon, Nice, Paris
2022-05-01
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
900
Nice
2022-04-29
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
22
Nice
2022-04-27
Recruiting
RIS International Cohort
NCT05388331Multiple Sclerosis, Radiologically Isolated Syndrome
Centre Hospitalier Universitaire de Nice
Observational
1,000
Nice
2022-04-15
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
27
Nice
2022-04-05
Active, closed
AstraZeneca
Phase 3
760
Angers, Clichy, Créteil, Montpellier, Nantes, Nice, Paris, Strasbourg
2022-03-28
Active, closed
MaaT013 As Salvage Therapy in Ruxolitinib Refractory GI-aGVHD Patients
NCT04769895Acute Graft Versus Host Disease in Intestine, Steroid Refractory GVHD
MaaT Pharma
Phase 3
66
Amiens, Angers, Caen, Grenoble, Lille, Marseille, Montpellier, Nice
2022-03-25
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
242
Nice
2022-03-14
Active, closed
BeOne Medicines
Phase 3
799
Antony, Le Mans, Montpellier, Nice, Paris, Strasbourg, VandoeuvrelesNancy
2022-03-10
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
43
Boulogne-Billancourt, Nice, Tourcoing, Tours
2022-03-07
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
66
Nice, Brest, Nantes, Angers, Marseille, Montpellier
2022-03-07
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
64
Nice
2022-03-04
Recruiting
Hanmi Pharmaceutical Company Limited
Phase 2
18
Clichy, Bordeaux, Lyon, Nice
2022-03-03
Recruiting
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Phase 2
310
Nice, Dijon, Besançon, Brest, Toulouse, Lille, Paris, Saint-Herblain
2022-02-17
Recruiting
Sanofi
Phase 3
284
Brest, Nice, Reims
2022-02-15
Active, closed
GE Healthcare
Phase 4
153
Dijon, La Tronche, Limoges, Lyon, Montpellier, Neuilly-sur-Seine, Nice, Paris
2022-02-08
Recruiting
Centre Antoine Lacassagne
Observational
200
Nice
2022-01-27
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
20
Nice
2022-01-25
Active, closed
Janssen Research & Development, LLC
Phase 3
350
Bayonne, Besançon, Colombes, Nantes, Nice, Paris, Pierre-Bénite, Reims
2022-01-19
Active, closed
Centre Leon Berard
Phase 2
58
Lyon, Bordeaux, Lille, Marseille, Nice, Poitiers, Reims, Rennes
2022-01-14
Active, closed
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
NCT05407636AMD, nAMD, Wet Age-related Macular Degeneration, wAMD
DrugsEylea·Aflibercept
AbbVie
Phase 3
735
Nice, Lyon, Dijon, Toulouse, Paris, Nantes, Marseille, Créteil
2022-01-13
Active, closed
Guardant Health, Inc.
Observational
12,000
Abbeville, Amiens, Caluire-et-Cuire, Contamine-sur-Arve, Le Kremlin-Bicêtre, Marseille, Nice, Pierre-Bénite
2022-01-13
Active, closed
Centre Hospitalier Universitaire de Besancon
Phase 2
55
Besançon, Dijon, Levallois-Perret, Lyon, Montbéliard, Nice, Paris, Poitiers
2022-01-04
Recruiting
Institut Curie
Not applicable
314
Caen, Dijon, Lille, Lyon, Marseille, Montpellier, Nice, Paris
2021-12-28
Active, closed
UNICANCER
Phase 2
53
Angers, Bordeaux, Caen, Dijon, Le Mans, Lyon, Montpellier, Nice
2021-12-17
Active, closed
Regeneron Pharmaceuticals
Phase 3
288
Nice, Le Kremlin-Bicêtre, Nancy, Paris
2021-12-14
Recruiting
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
NCT05176483Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Urothelial Carcinoma (UC), Solid Tumor
DrugsZanzalintinib·Relatlimab·Yervoy·Ipilimumab
Exelixis
Phase 1
1,394
Besançon, Bordeaux, Caen, Clermont-Ferrand, Lyon, Marseille, Nice, Paris
2021-12-14
Recruiting
Leiden University Medical Center
Phase 3
316
Besançon, Bordeaux, Lyon, Marseille, Montpellier, Nice, Saint-Herblain, Strasbourg
2021-11-11
Active, closed
Amgen
Phase 3
303
Créteil, Dijon, Le Chesnay, Lille, Marseille, Nantes, Nice, Paris
2021-11-02
Active, closed
Hoffmann-La Roche
Phase 3
478
Bayonne, Chambéry, Créteil, Lille, Marseille, Montpellier, Nantes, Nice
2021-10-27
Active, closed
Immunotherapy in MSI/dMMR Tumors in Perioperative Setting.
NCT04795661Localized Resectable Tumor, MSI/dMMR
DrugPembrolizumab
Centre Leon Berard
Phase 2
240
Amiens, Clermont-Ferrand, Dijon, Lille, Lyon, Marseille, Montpellier, Nice
2021-10-18
Active, closed
AbbVie
Phase 1
520
Bordeaux, Saint-Herblain, Nice, Lyon, Villejuif, Dijon, Paris
2021-10-13
Recruiting
Centre Hospitalier Universitaire de Nīmes
Not applicable
256
Toulouse, Clermont-Ferrand, Montpellier, Nice, Nîmes, Thuir
2021-09-27
Active, closed
Study of INBRX-109 in Conventional Chondrosarcoma
NCT04950075Conventional Chondrosarcoma
DrugINBRX-109
Inhibrx Biosciences, Inc
Phase 2
206
Bordeaux, Lille, Lyon, Marseille, Montpellier, Nice, Paris, Rennes
2021-09-23
Active, closed
Mirum Pharmaceuticals, Inc.
Phase 2
333
Grenoble, Lille, Nice, Paris, Strasbourg, Villejuif
2021-09-22
Active, closed
A Non-interventional Cohort Safety Study of Patients With hATTR-PN
NCT04850105Hereditary Transthyretin Amyloidosis With Polyneuropthy
Akcea Therapeutics
Observational
202
Lille, Nice, Nantes
2021-09-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
2,000
Nice, Dijon, Bordeaux, Toulouse, Rouen, Montpellier, Nantes, Tourcoing
2021-09-15
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
115
Nice, Perpignan
2021-09-15
Active, closed
Boston Scientific Corporation
Not applicable
155
Aix-en-Provence, Angers, Bordeaux, Grenoble, Lille, Lyon, Nice, Paris
2021-09-15
Active, closed
Centre Hospitalier Universitaire de Nice
Phase 4
60
Nice
2021-09-09
Active, closed
Janssen Pharmaceutica N.V., Belgium
Observational
1,314
Bobigny, Cholet, Clermont-Ferrand, Créteil, Échirolles, Lille, Lyon, Nice
2021-08-25
Recruiting
medac GmbH
Phase 3
210
Amiens, Besançon, Grenoble, Lille, Nantes, Nice, Pierre-Bénite, Toulouse
2021-08-16
Active, closed
AstraZeneca
Phase 3
712
Amiens, Bayonne, Clermont-Ferrand, Lille, Lyon, Marseille, Montpellier, Nice
2021-08-05
Recruiting
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
NCT04913285Solid Tumor, Adult, Non-small Cell Lung Cancer, Melanoma
Pierre Fabre Medicament
Phase 1
400
Bordeaux, Caen, Lille, Lyon, Marseille, Nantes, Nice, Paris
2021-08-04
Recruiting
Virtual Reality for Children in Radiotherapy (REVER)
NCT04934293Virtual Reality, Proton Therapy, Pediatric Cancer
Centre Antoine Lacassagne
Not applicable
47
Nice
2021-08-02
Active, closed
Novartis Pharmaceuticals
Phase 3
208
Lille, Nantes, Nice, Paris, Toulouse
2021-07-27
Recruiting
Centre Antoine Lacassagne
Phase 2
40
Clermont-Ferrand, Nice
2021-07-16
Active, closed
VectivBio AG
Phase 3
158
Clichy, Lyon, Nantes, Nice, Pessac, Vandœuvre-lès-Nancy
2021-07-13
Recruiting
ImmunoVaccine Technologies, Inc. (IMV Inc.)
Phase 2
102
Bobigny, Nancy, Nantes, Nice, Paris, Pessac, Périgueux, Saint-Quentin
2021-06-18
Recruiting
ATF Implants
Observational
4,500
Bordeaux, Cornebarrieu, Échirolles, Guilherand-Granges, Marcq-en-Barœul, Nice, Paris, Poitiers
2021-06-07
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
200
Gentilly, Lille, Nice, Paris, Rouen
2021-06-02
Recruiting
Impact of Auditory Stimulation in Eating Pleasure (EDERE 2021)
NCT04923087Frailty, Malnutrition, Anorexia, Presbycusis
Centre Hospitalier Universitaire de Nice
Observational
100
Nice
2021-06-01
Recruiting
A Study of BGB-11417 in Participants With Myeloid Malignancies
NCT04771130Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasm
DrugsPosaconazole·Sonrotoclax·Azacitidine
BeOne Medicines
Phase 1/2
260
Lille, Nice, Paris
2021-05-24
Active, closed
Bristol-Myers Squibb
Phase 3
681
Nice, Suresnes, Villejuif
2021-05-21
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
15
Nice
2021-05-18
Active, closed
Merck Sharp & Dohme LLC
Phase 3
815
Nice, Pessac, Strasbourg, Brest, Toulouse, Lille, La Tronche, Saint-Herblain
2021-05-12
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
139
Dijon, Limoges, Lyon, Marseille, Montpellier, Nice, Paris, Saint-Herblain
2021-05-11
Recruiting
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
NCT04614103Metastatic Non Small Cell Lung Cancer
DrugLifileucel
Iovance Biotherapeutics, Inc.
Phase 2
170
Marseille, Nantes, Nice, Pierre-Bénite, Poitiers, Villejuif
2021-05-07
Active, closed
AstraZeneca
Phase 3
1,157
Avignon, Besançon, Bordeaux, Caen, Le Mans, Montpellier, Nice, Paris
2021-04-26
Recruiting
RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
NCT04796350Fragility Fracture, Hip Fractures, Osteoporosis
AgNovos Healthcare, LLC
Not applicable
2,400
Nice, Amiens, Grenoble, Lyon, Toulouse
2021-04-24
Recruiting
GlaxoSmithKline
Phase 2
37
Nantes, Nice
2021-04-16
Active, closed
Geron Corporation
Phase 3
327
Pierre-Bénite, Tours, Paris, Nantes, Nice, Le Mans, Brest
2021-04-12
Active, closed
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
NCT04603495Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugsPelabresib·Ruxolitinib
Novartis Pharmaceuticals
Phase 3
430
Amiens, Le Mans, Nice, Nîmes, Pierre-Bénite, Rennes, Saint-Priest-en-Jarez, Tours
2021-04-09
Recruiting
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
NCT04728893Hematologic Malignancies, Waldenstroms Macroglobulinaemia, Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia
DrugNemtabrutinib
Merck Sharp & Dohme LLC
Phase 2
490
Nice, Pierre-Bénite, Marseille, Le Chesnay, Paris
2021-04-05
Active, closed
Novo Nordisk A/S
Phase 3
1,205
Angers, Clichy, Lille, Lyon, Nice, Paris, Pessac, Pierre-Bénite
2021-04-01
Recruiting
Molecular Signature From Tumor to Lymph Nodes
NCT04677205Lung Cancer, Stage IIIA-cN2, Operated With Curative Intent, Primary Tumor Tissue Available
Assistance Publique - Hôpitaux de Paris
Observational
200
Bordeaux, Clamart, Marseille, Nice, Paris, Rennes, Strasbourg, Toulouse
2021-03-30
Active, closed
Hoffmann-La Roche
Phase 3
751
Clermont-Ferrand, Nice, Rouen, Toulouse
2021-03-24
Recruiting
Bristol-Myers Squibb
Phase 3
153
Calais, Dijon, Nice, Paris
2021-03-23
Active, closed
Bristol-Myers Squibb
Phase 1/2
216
Brest, Marseille, Nice, Paris, Villejuif
2021-03-22
Recruiting
Calico Life Sciences LLC
Phase 1
248
Marseille, Toulouse, Nice, Suresnes
2021-03-09
Active, closed
Merck Sharp & Dohme LLC
Phase 3
747
Reims, Nice, Strasbourg, Bordeaux, Toulouse, Limoges, Saint-Herblain, Angers
2021-02-25
Active, closed
Celgene
Phase 3
313
Angers, Clermont-Ferrand, Créteil, Grenoble, Lille, Lyon, Nice, Nîmes
2021-02-25
Recruiting
Institut Cancerologie de l'Ouest
Phase 2
262
Angers, Bordeaux, Montpellier, Nice, Paris, Saint-Herblain, Toulouse
2021-02-03
By invitation
Centre Hospitalier Universitaire de Nice
Observational
1,200
Nice
2021-02-01
Recruiting
IL17 Rate and Spondyloarthritis
NCT05592574Spondylarthritis
Centre Hospitalier Universitaire de Nice
Observational
50
Nice
2021-02-01
Active, closed
Galderma R&D
Phase 3
500
Bordeaux, Brest, Nantes, Nice, Paris, Pierre-Bénite, Rouen, Saint-Etienne
2021-01-11
Active, closed
Merck Sharp & Dohme LLC
Phase 3
990
Vandœuvre-lès-Nancy, Nice, Caen, Plérin, Besançon, Bordeaux, Toulouse, Montpellier
2021-01-10
Active, closed
Amgen
Phase 1/2
181
Le Chesnay, Lille, Nice, Paris, Pierre-Bénite, Toulouse
2021-01-04
Active, closed
Pullback Pressure Gradient (PPG) Global Registry
NCT04789317Chronic Coronary Insufficiency, Non ST Elevation Myocardial Infarction
VZW Cardiovascular Research Center Aalst
Observational
982
Nice
2020-12-23
Recruiting
Predictive Toxicity Test Linked to Radiotherapy After Mastectomy and Immediate Implant Reconstruction
NCT04342546Breast Cancer, Capsular Contracture Associated With Breast Implant
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
250
Dijon, Lille, Lyon, Marseille, Montpellier, Nice, Paris, Saint-Herblain
2020-12-11
Active, closed
GlaxoSmithKline
Phase 2/3
758
Créteil, Grenoble, Marseille, Nice, Quimper, Rennes, Tours
2020-12-08
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
20
Nice
2020-11-24
Active, closed
AstraZeneca
Phase 3
957
Avignon, Besançon, Brest, Dijon, Lyon, Montpellier, Nantes, Nice
2020-11-17
Recruiting
Meril Life Sciences Pvt. Ltd.
Not applicable
988
Créteil, Lille, Massy, Nice, Rennes
2020-11-04
Recruiting
Metabolomics of Cancers of the Upper Aerodigestive Tract
NCT07377084Upper AerodigestiveTract Cancer
DrugUrine samples
Centre Antoine Lacassagne
Observational
250
Nice
2020-11-04
Active, closed
Centre Hospitalier Universitaire de Nice
Phase 4
60
Nice, Marseille
2020-11-02
Active, closed
Hoffmann-La Roche
Phase 3
985
Bordeaux, Bron, Montpellier, Nantes, Nice, Strasbourg
2020-10-26
Active, closed
Provention Bio, a Sanofi Company
Observational
188
Orléans, Bron, Dijon, Marseille, Nice, Paris, Pau
2020-10-26
Active, closed
Myasthenia Gravis Inebilizumab Trial
NCT04524273Myasthenia Gravis
DrugInebilizumab
Amgen
Phase 3
238
Lille, Nice, Strasbourg
2020-10-15
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
70
Nice
2020-10-10
Active, closed
A Gene Transfer Study for Late-Onset Pompe Disease (RESOLUTE)
NCT04093349Pompe Disease, Pompe Disease (Late-onset), Glycogen Storage Disease Type 2, Glycogen Storage Disease Type II
Spark Therapeutics, Inc.
Phase 1/2
4
Angers, Garches, Lille, Marseille, Nice
2020-10-01
Active, closed
University of Zurich
Not applicable
986
Dijon, Lyon, Marseille, Nice, Toulouse
2020-09-30
Active, closed
AbbVie
Phase 3
527
Nice, Clermont, Marseille, Pessac, Montpellier, La Tronche, Reims, Vandœuvre-lès-Nancy
2020-09-30
Active, closed
argenx
Phase 2
229
Angers, Bordeaux, Clermont-Ferrand, Le Kremlin-Bicêtre, Limoges, Nantes, Nice, Paris
2020-09-18
Active, closed
AbbVie
Phase 3
531
Nice, Pessac, La Tronche, Lille, Nantes, Marseille, Rouen, Avignon
2020-09-10
Active, closed
AbbVie
Phase 3
330
Nice, Nîmes, Pessac, Nantes, Pierre-Bénite, Chambéry, Angers, Paris
2020-08-31
Recruiting
Takeda
Phase 2
210
Angers, Épagny, Nantes, Nice, Paris, Pontoise, Talence
2020-08-19
Recruiting
Centre Hospitalier Universitaire de Nice
Phase 2
40
Bron, Clermont-Ferrand, Marly, Montpellier, Nice
2020-08-11
Recruiting
Eisai Inc.
Phase 1/2
182
Nice, Strasbourg, Marseille, Caen, Saint-Brieuc, Nantes, Lille, Bayonne
2020-08-06
Active, closed
Incyte Corporation
Phase 2
112
Brest, Nice, Paris, Toulouse, Tours
2020-08-03
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
1,000
Nice
2020-07-28
Active, closed
Centre Antoine Lacassagne
Phase 2
155
Cagnes-sur-Mer, Mougins, Nice
2020-07-20
Active, closed
AstraZeneca
Phase 3
1,012
Besançon, Bordeaux, Marseille, Montpellier, Nice, Paris, Pierre-Bénite, Quimper
2020-07-13
Recruiting
Institut Cancerologie de l'Ouest
Observational
300
Angers, La Roche-sur-Yon, Lyon, Montpellier, Nantes, Nice, Saint-Cloud, Suresnes
2020-07-10
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
400
Nice
2020-07-04
Active, closed
Actelion
Phase 3
935
Brest, Caen, Le Kremlin-Bicêtre, Lille, Marseille, Nice, Saint-Priest-en-Jarez, Toulouse
2020-06-30
Active, closed
Centre Hospitalier Universitaire de Nice
Observational
90
Nice
2020-06-16
Recruiting
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
NCT04389632Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, HER2 Negative Breast Neoplasms, Esophageal Squamous Cell Carcinoma
DrugsSigvotatug vedotin·Keytruda·Cisplatin·Carboplatin
Seagen, a wholly owned subsidiary of Pfizer
Phase 1
1,006
Angers, Nice, Poitiers, Vandœuvre-lès-Nancy, Villejuif
2020-06-08
Recruiting
Centre Antoine Lacassagne
Phase 2
103
Bordeaux, Caen, Dijon, Lille, Lyon, Marseille, Montpellier, Nice
2020-06-04
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
300
Nice
2020-06-01
Recruiting
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
NCT04256317Myelodysplastic Syndromes, Acute Myeloid Leukemia, Myelodysplastic Syndrome/Neoplasm, Chronic Myelomonocytic Leukemia
DrugsVenclexta·Azacitidine·Venetoclax
Taiho Oncology, Inc.
Phase 2/3
316
Toulouse, Nice, Paris
2020-05-21
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
144
Nice, Paris
2020-05-20
Recruiting
Assessment of Chilbains Occuring During Covid-19 Infection
NCT04344119Skin Manifestations, COVID, Chilblains
Centre Hospitalier Universitaire de Nice
Observational
30
Nice
2020-04-09
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
886
Bordeaux, Lyon, Nice, Pierre-Bénite, Strasbourg, Tours, Villejuif-Cedex-France
2020-03-30
Active, closed
First-in-Human Study of ICT01 in Patients With Advanced Cancer
NCT04243499Solid Tumor, Adult, Hematopoietic/Lymphoid Cancer
ImCheck Therapeutics, an Ipsen company
Phase 1/2
293
Bordeaux, Lyon, Marseille, Nantes, Nice, Paris, Poitiers
2020-03-05
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
20
Lyon, Lille, Montpellier, Toulouse, Marseille, Nice, Paris
2020-02-25
Recruiting
Hospices Civils de Lyon
Phase 1/2
26
Pierre-Bénite, Bordeaux, Caen, Lille, Marseille, Nice, Paris, Rennes
2020-02-12
Recruiting
AiCR : Artificial Intelligence in Cardiac aRrest
NCT04462380Cardio Respiratory Arrest
Centre Hospitalier Universitaire de Nice
Observational
500
Nice
2020-02-01
Recruiting
Centre Leon Berard
Phase 2
455
Angers, Bordeaux, Caen, Lyon, Marseille, Nice, Paris, Rouen
2020-01-28
Active, closed
UNICANCER
Phase 3
490
Albi, Angers, Bordeau, Dijon, Le Puy-en-Velay, Lille, Montpellier, Nice
2020-01-09
Recruiting
Centre Antoine Lacassagne
Observational
40,000
Nice
2020-01-07
Recruiting
Sumitomo Pharma America, Inc.
Phase 1/2
240
Amiens, Angers, Lyon, Nice, Nîmes, Paris, Poitiers, Villejuif
2019-12-16
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
30
Nice
2019-12-12
Recruiting
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
NCT04071847Movement Disorders, Parkinson Disease, Essential Tremor, Tremor
Abbott Medical Devices
Observational
1,000
Clermont-Ferrand, Saint-Etienne, Paris, Nice
2019-11-26
Active, closed
AbbVie
Phase 1
85
Nice, Amiens, Paris, Toulouse
2019-11-08
Active, closed
AbbVie
Phase 1/2
218
Marseille, Toulouse, Paris, Nice, Pierre-Bénite, Le Chesnay
2019-11-06
Active, closed
Bristol-Myers Squibb
Phase 3
790
Brest, Besançon, Bordeaux, Lille, Marseille, Nantes, Nice, Paris
2019-10-28
Active, closed
Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer
NCT04050436Cutaneous Squamous Cell Carcinoma, Advanced Cutaneous Squamous Cell Carcinoma, Metastatic Cutaneous Squamous Cell Carcinoma
DrugsVusolimogene Oderparepvec·Cemiplimab
Replimune, Inc.
Phase 2
231
Besançon, Dijon, La Tronche, Lille, Lyon, Marseille, Nice, Paris
2019-10-08
Active, closed
NeuroDerm Ltd.
Phase 3
381
Bron, Clermont-Ferrand, Nantes, Nice, Nîmes, Toulouse
2019-09-30
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Caen, Clichy, Lille, Montpellier, Nice, Paris, Pessac, Pierre-Bénite
2019-09-26
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
43
Nice
2019-09-20
Active, closed
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
NCT04083599Malignant Solid Tumor, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Melanoma
DrugsGEN1042·Adrucil·Nab-paclitaxel·Pemetrexed
Genmab
Phase 1/2
350
Bordeaux, Nice, Villejuif
2019-09-17
Active, closed
Clinical Trial Readiness Network FSHD France: Prospective 24 Months MRI Study
NCT04038138Muscular Dystrophy, Facioscapulohumeral
Centre Hospitalier Universitaire de Nice
Not applicable
100
Lille, Nice, Paris
2019-09-16
Recruiting
LAparoscopic Preventive PRErectal Mesh
NCT03766048Urogenital Prolapse
University Hospital, Lille
Not applicable
834
Clermont-Ferrand, Dunkirk, La Rochelle, Le Mans, Lille, Nice, Nîmes, Poissy
2019-09-11
Active, closed
Pfizer
Phase 3
896
Amiens, Grenoble, Montpellier, Nantes, Nice, Toulouse
2019-09-05
Recruiting
Centre Antoine Lacassagne
Phase 1
27
Nice
2019-08-02
Active, closed
Institut National de la Santé Et de la Recherche Médicale, France
Observational
45
Nice
2019-07-20
Active, closed
Centre Hospitalier Universitaire de Nice
Observational
1,400
Nice
2019-07-03
Active, closed
AstraZeneca
Phase 3
923
Brest, Lyon, Marseille, Montpellier, Nice, Paris, Saint-Herblain, Villejuif
2019-06-25
Active, closed
Exelixis
Phase 3
855
Bordeaux, Le Mans, Lyon, Montpellier, Nice, Paris, Reims, Rennes
2019-06-25
Active, closed
Bristol-Myers Squibb
Phase 3
437
Nice, Brest, Nancy, Valenciennes, Angers, Besançon, Caen, Hyères
2019-06-21
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
1,210
Villejuif, Besançon, Cergy-Pontoise, Clermont-Ferrand, Fort de France, Guadeloupe, Mougins, Nice
2019-06-06
Active, closed
Regeneron Pharmaceuticals
Phase 3
415
Dijon, Bordeaux, Boulogne-Billancourt, La Tronche, Lille, Lyon, Nantes, Nice
2019-06-04
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
109
Nice
2019-06-03
Active, closed
LEO Pharma
Phase 2
131
Bordeaux, Nice, Paris, Reims
2019-05-29
Active, closed
Nuvaira, Inc.
Not applicable
464
Grenoble, Toulouse, Brest, Montpellier, Nice, Paris, Reims, Strasbourg
2019-05-23
Active, closed
AstraZeneca
Phase 3
810
Clichy, Dijon, Montpellier, Nice, Paris, Pessac, Poitiers
2019-04-16
Active, closed
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 3
377
Nice, Caen, Rennes, Reims, Perpignan, Lyon, Villejuif, Montpellier
2019-03-28
Active, closed
Avelumab Program Rollover Study
NCT03815643Solid Tumors
DrugAvelumab
EMD Serono Research & Development Institute, Inc.
Phase 3
205
Besançon, Lille, Nantes, Nice, Paris, Pessac, Poitiers, Strasbourg
2019-03-22
Active, closed
Institut de Recherches Internationales Servier
Phase 3
856
Avignon, Besançon, Brest, Lyon, Montbéliard, Nice, Paris, Pessac
2019-03-21
Active, closed
Hoffmann-La Roche
Phase 3
1,000
Angers, Nice, Lille, Marseille, Villejuif
2019-02-28
Recruiting
University Hospital, Tours
Observational
150
Bordeaux, Grenoble, Lyon, Marseille, Nantes, Nice, Paris, Rennes
2019-02-04
Active, closed
Janssen Research & Development, LLC
Phase 3
765
Besançon, Bordeaux, Clermont-Ferrand, Lyon, Montpellier, Nancy, Nice, Paris
2019-01-25
Recruiting
Cutaneous and Mucosal Manifestations of Neurofribromatosis Type 2 in Children Under 15
NCT03893643Neurofibromatosis 2, Dermatology/Skin - Other
Centre Hospitalier Universitaire de Nice
Observational
1,000
Nice
2019-01-01
Active, closed
Jules Bordet Institute
Phase 1/2
129
Besançon, Bordeaux, Dijon, Marseille, Nice, Paris, Poitiers, Rouen
2018-12-28
Active, closed
Novartis Pharmaceuticals
Phase 3
1,882
Lille, Montpellier, Nantes, Nice, Nîmes, Paris, Strasbourg
2018-12-28
Active, closed
Merck Sharp & Dohme LLC
Phase 3
714
Nice, Marseille, Toulouse, Villejuif, Avignon, Paris
2018-12-17
Active, closed
UNICANCER
Phase 2
79
Bordeaux, Clermont-Ferrand, Dijon, Lille, Montpellier, Mougins, Nice, Paris
2018-12-14
Active, closed
Merck Sharp & Dohme LLC
Phase 2
329
Poitiers, Nice, Strasbourg, Dijon, Bordeaux, Villejuif
2018-12-12
Active, closed
Novartis Pharmaceuticals
Phase 3
5,101
Nice, Dijon, Limoges, Saint-Cloud, Rennes, Grenoble, Lyon, Amiens
2018-12-07
Active, closed
AstraZeneca
Phase 3
825
Avignon, Lyon, Nice, Toulon, Vantoux
2018-12-06
Active, closed
AstraZeneca
Phase 3
724
Bobigny, Clichy, Grenoble, Montpellier, Nice, Paris, Pessac, Toulouse
2018-11-30
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
30
Nice
2018-11-07
Active, closed
Exelixis
Phase 3
187
Dijon, Bordeaux, Angers, Marseille, Besançon, Lyon, Nice, Paris
2018-10-05
Active, closed
AbbVie
Phase 3
1,242
Nice, Marseille, Montpellier, Vandœuvre-lès-Nancy, Pessac, Saint Priest EN Jarez, Amiens, Nantes
2018-08-28
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Nice, Strasbourg, Pessac, Pierre-Bénite, Lyon, Marseille, Caen, Dijon
2018-08-21
Active, closed
AbbVie
Phase 3
1,533
Nice, Marseille, Tours, Bordeaux, Reims
2018-08-09
Active, closed
Eli Lilly and Company
Phase 3
1,058
Amiens, Chambray-lès-Tours, Lille, Montpellier, Neuilly-sur-Seine, Nice, Paris, Pau
2018-07-18
Active, closed
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
140
Nice, Caen, Dijon, Pessac, Toulouse, Clichy, Montpellier, Chambray-lès-Tours
2018-06-26
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Observational
150
Villejuif, Créteil, Lille, Lyon, Marseille, Montpellier, Nantes, Nice
2018-06-22
Active, closed
A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.
NCT03504397Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsFolinic acid·Zolbetuximab·Fluorouracil·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
565
Dijon, Brest, Rennes, Besançon, Montpellier, Paris, Saint-Herblain, Nice
2018-06-21
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
890
Pierre-Bénite, Dijon, Bordeaux, Caen, Nice, Lyon, Villejuif
2018-05-21
Recruiting
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
NCT03526835Advanced/Metastatic Solid Tumors, Colorectal Cancer, Gastric Cancer, Gastroesophageal-junction Cancer
DrugPetosemtamab
Merus B.V.
Phase 1/2
560
Bordeaux, Lyon, Marseille, Montpellier, Nice, Paris, Rouen
2018-05-02
Active, closed
AbbVie
Phase 3
1,336
Nice, Montpellier, La Tronche, Vandœuvre-lès-Nancy, Pessac, Lille, St-Priest-en-Jarez, Pierre-Bénite
2018-04-09
Active, closed
AbbVie
Phase 3
747
Nice, Pessac, Toulouse, Montpellier, La Tronche, Vandœuvre-lès-Nancy, Lille, Valenciennes
2018-03-21
Recruiting
FARD (RaDiCo Cohort) (RaDiCo-FARD)
NCT05954416Inherited Epidermolysis Bullosa, Ichthyosis, Ectodermal Dysplasia, Incontinentia Pigmenti
Institut National de la Santé Et de la Recherche Médicale, France
Observational
900
Bobigny, Bordeaux, Créteil, Dijon, Limoges, Marseille, Montpellier, Nice
2018-03-07
Active, closed
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
NCT03458832Facioscapulohumeral Muscular Dystrophy
University of Kansas Medical Center
Observational
324
Nice, Paris
2018-03-05
Active, closed
Fondation Lenval
Not applicable
728
Nice
2017-11-21
Active, closed
AstraZeneca
Phase 3
1,324
Clichy, Lille, Marseille, Montpellier, Nancy, Nantes, Nice, Pessac
2017-10-11
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
136
Nice
2017-09-30
Active, closed
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers
NCT03212404Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Small Cell, Malignant Mesothelioma, Advanced
Checkpoint Therapeutics, Inc.
Phase 1
272
Besançon, Bordeaux, Grenoble, Lyon, Nice
2017-09-20
Active, closed
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)
NCT03767348Non-Small Cell Lung Cancer (NSCLC), Microsatellite Instability-High (MSI-H), Non-melanoma Skin Cancer (NMSC), Cutaneous Melanoma
DrugsVusolimogene Oderparepvec·Opdivo·Nivolumab
Replimune, Inc.
Phase 2
340
Besançon, Bordeaux, Dijon, Lyon, Marseille, Nice, Paris, Villejuif
2017-09-20
Active, closed
Hoffmann-La Roche
Phase 3
382
Besançon, Grenoble, Lyon, Marseille, Nantes, Nice, Paris, Pierre-Bénite
2017-09-20
Recruiting
Charite University, Berlin, Germany
Phase 2
250
Nice
2017-09-01
Active, closed
Hoffmann-La Roche
Phase 2
316
Bordeaux, Clermont-Ferrand, Créteil, Grenoble, Marseille, Nice, Paris, Poitiers
2017-06-27
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
200
Draguignan, Marseille, Nice, Ollioules
2017-04-12
Recruiting
Turning Point Therapeutics, Inc.
Phase 1/2
500
Marseille, Brest, Dijon, Grenoble, Nice, Poitiers, Saint-Mandé, Villejuif
2017-03-07
Active, closed
AbbVie
Phase 3
950
Nice, Montpellier, Lille, Pierre-Bénite, La Roche-sur-Yon, Saint-Etienne
2017-01-31
Active, closed
Feasibility of Molecular Biology in Pancreatic Cyst Tumors
NCT03305146Pancreatic Cyst, Pancreas Cyst, Serous Cystadenoma, Mucinous Cystadenoma
Hospital St. Joseph, Marseille, France
Not applicable
93
Charenton-le-Pont, Limoges, Lyon, Marseille, Nantes, Nice, Paris, Vichy
2017-01
Active, closed
Janssen Biotech, Inc.
Observational
535
Clermont-Ferrand, Clichy, Créteil, Grenoble, Montpellier, Nice, Pierre-Bénite, Saint-Priest-en-Jarez
2016-12-16
Active, closed
Target PharmaSolutions, Inc.
Observational
10,000
Nice, Paris
2016-12
Active, closed
Centre Hospitalier Universitaire de Nīmes
Observational
100
Besançon, Créteil, Dijon, Limoges, Nancy, Nice, Nîmes, Strasbourg
2016-11-16
Recruiting
University Hospital, Grenoble
Not applicable
60
Créteil, Grenoble, Nice, Paris
2016-09
Active, closed
Eli Lilly and Company
Phase 2
309
Lyon, Bordeaux, Besançon, Lille, Montpellier, Nice, Villejuif
2016-05-19
Active, closed
Geron Corporation
Phase 2/3
289
Nice, Tours, Limoges, La Tronche, Vandœuvre-lès-Nancy, Le Mans, Poitiers, Angers
2016-01-12
Active, closed
Drug-Eluting Balloon Angioplasty for the Treatment of Hemodialysis Vascular Access Stenosis (DEBAVAS)
NCT02408822Dysfunction of Hemodialysis Vascular Access (Fistula and Graft)
Centre Hospitalier Universitaire de Nice
Not applicable
52
Nice, Reims
2015-09-29
Active, closed
Taiho Oncology, Inc.
Phase 1/2
253
Villejuif, Pierre-Bénite, Bordeaux, Nice, Rouen, Toulouse, Tours
2015-07-14
Active, closed
Centre Antoine Lacassagne
Phase 3
148
Lyon, Besançon, Reims, Marseille, Mâcon, Nice, Pierre-Bénite, Saint-Priest-en-Jarez
2015-06-24
Active, closed
Centre Antoine Lacassagne
Phase 1/2
51
Nice
2015-06
Recruiting
Surgery for Recurrent Glioblastoma
NCT02394626Glioblastoma
Insel Gruppe AG, University Hospital Bern
Phase 2
120
Dijon, Lyon, Marseille, Nice, Paris, Saint-Etienne, Strasbourg, Tours
2015-05-01
Active, closed
Janssen Research & Development, LLC
Phase 2
239
Angers, Bordeaux, Caen Cédex 05, Dijon, Lyon, Nice, Nîmes, Paris
2015-04-22
Active, closed
Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma
NCT02243605Metastatic Ewing Sarcoma, Metastatic Osteosarcoma, Recurrent Ewing Sarcoma, Recurrent Osteosarcoma
DrugsCabozantinib S-malate·Cabozantinib
National Cancer Institute (NCI)
Phase 2
90
Bordeaux, Dijon, Lille, Lyon, Marseille, Nice, Paris, Saint-Herblain
2014-12-19
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
50
Nice
2014-11-05
Active, closed
University Hospital, Toulouse
Observational
1,700
Bordeaux, Clichy, Lille, Lyon, Marseille, Montpellier, Nice, Paris
2014-05
Recruiting
Observational Study to Evaluate Long-Term Outcome in Hip Arthroplasty
NCT02230826Hip Replacement, Primary, Secondary or Post-traumatic Osteoarthrosis, Femur Head Necrosis, Congenital Dislocations
Corin
Observational
2,500
Bordeaux, Cannes, Dunkirk, Hénin-Beaumont, Nice, Orléans, Paris, Pessac
2014-05
Active, closed
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
154
Villejuif, Avignon, Caen, Dijon, Lille, Marseille, Montpellier, Nice
2014-02-26
Recruiting
Inflatable Penile Prostheses : Which Patients Can Correctly Use the Scrotal Pump ?
NCT04390230Surgery, Satisfaction, Penile Prosthesis; Complications
Centre Hospitalier Universitaire de Nice
Observational
120
Nice
2014-01-24
Active, closed
MedImmune LLC
Phase 2
571
Caen, Le Mans, Lille, Nice, Rennes, Toulouse, Villejuif
2013-05-17
Active, closed
AbbVie
Observational
8,250
Nice, Clermont, Marseille, Toulouse, Montpellier, La Tronche, Reims, Vandœuvre-lès-Nancy
2013-04-29
Active, closed
Radical Fimbriectomy for Young BRCA Mutation Carriers
NCT01608074BRCA1 Mutation, BRCA2 Mutation, Hereditary Breast and Ovarian Cancer
Centre Oscar Lambret
Not applicable
123
Aix-en-Provence, Bordeaux, Clermont-Ferrand, Lille, Lyon, Marseille, Nice, Paris
2012-01-09
Recruiting
Characterization of the Mechanisms of Resistance to Azacitidine
NCT01210274Myelodysplastic Syndromes or Acute Myeloid Leukemia With Multilineage Dysplasia
Centre Hospitalier Universitaire de Nice
Observational
250
Antibes, Nice
2010-09
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
40
Nice, Lille, Marseille, Nantes, Nîmes, Paris, Poitiers, Rennes
2010-01-01
Active, closed
Alliance for Clinical Trials in Oncology
Phase 3
305
Lyon, Nice, Villejuif
2009-09
Active, closed
Minimal SN Tumor Burden
NCT01942603Cutaneous Melanoma
European Organisation for Research and Treatment of Cancer - EORTC
Observational
296
Lille, Nice, Paris
2009-07
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
751
Marseille, Nancy, Nice, Paris, Rennes, Villejuif
2007-12
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
—
Nice
2005-01-01
Recruiting
Nice Human Immunodeficiency Virus (HIV) Cohort
NCT03690063Human Immunodeficiency Virus
Centre Hospitalier Universitaire de Nice
Observational
2,000
Nice
1996-01-01
By invitation
Copenhagen University Hospital, Rigshospitalet
Observational
23,000
Bordeaux, Lyon, Nice, Paris
1994-01
Recruiting
Nantes University Hospital
Observational
30,000
Lyon, Montpellier, Nancy, Nice, Paris, Toulouse
1994-01
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
615
Bordeaux, Caen, Compiègne, Dijon, Lyon, Nice, Paris, Pierre-Bénite
1989-09
Rows per page Showing 501–768 of 768
Previous 1 2
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 October 2026. https://priyalifescience.com/clinical-trials-france/city/nice?page=2

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,697 studies in total at the last sync on 26 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 768 of those studies with a site in Nice.

How many clinical trials are recruiting in Nice?

411 of the 768 studies on this page are recruiting new participants as of the 26 Oct 2026, 03:20 UTC sync. A further 60 have not yet opened recruitment, 286 are active but closed to new participants, and 11 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.